405 related articles for article (PubMed ID: 19369356)
1. Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions.
Kang H; Lieberman PM
J Virol; 2009 Jun; 83(12):6199-210. PubMed ID: 19369356
[TBL] [Abstract][Full Text] [Related]
2. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators.
Stedman W; Kang H; Lin S; Kissil JL; Bartolomei MS; Lieberman PM
EMBO J; 2008 Feb; 27(4):654-66. PubMed ID: 18219272
[TBL] [Abstract][Full Text] [Related]
3. Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency.
Chen HS; Wikramasinghe P; Showe L; Lieberman PM
J Virol; 2012 Sep; 86(17):9454-64. PubMed ID: 22740398
[TBL] [Abstract][Full Text] [Related]
4. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
Li D; Mosbruger T; Verma D; Swaminathan S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
[TBL] [Abstract][Full Text] [Related]
5. CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription.
Li DJ; Verma D; Mosbruger T; Swaminathan S
PLoS Pathog; 2014 Jan; 10(1):e1003880. PubMed ID: 24415941
[TBL] [Abstract][Full Text] [Related]
6. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation.
Kang H; Wiedmer A; Yuan Y; Robertson E; Lieberman PM
PLoS Pathog; 2011 Aug; 7(8):e1002140. PubMed ID: 21876668
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion.
Kang H; Lieberman PM
J Virol; 2011 Nov; 85(21):11159-69. PubMed ID: 21880767
[TBL] [Abstract][Full Text] [Related]
8. CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming.
Kang H; Cho H; Sung GH; Lieberman PM
J Virol; 2013 Feb; 87(3):1789-99. PubMed ID: 23192870
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection.
Toth Z; Smindak RJ; Papp B
Virology; 2017 Dec; 512():25-33. PubMed ID: 28898712
[TBL] [Abstract][Full Text] [Related]
10. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.
Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM
PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481
[TBL] [Abstract][Full Text] [Related]
11. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
12. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program.
Li Q; Zhou F; Ye F; Gao SJ
Virology; 2008 Sep; 379(2):234-44. PubMed ID: 18684478
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus.
Schifano JM; Corcoran K; Kelkar H; Dittmer DP
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928018
[TBL] [Abstract][Full Text] [Related]
15. Role of CCCTC binding factor (CTCF) and cohesin in the generation of single-cell diversity of protocadherin-α gene expression.
Monahan K; Rudnick ND; Kehayova PD; Pauli F; Newberry KM; Myers RM; Maniatis T
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9125-30. PubMed ID: 22550178
[TBL] [Abstract][Full Text] [Related]
16. A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection.
Deng Z; Wang Z; Stong N; Plasschaert R; Moczan A; Chen HS; Hu S; Wikramasinghe P; Davuluri RV; Bartolomei MS; Riethman H; Lieberman PM
EMBO J; 2012 Nov; 31(21):4165-78. PubMed ID: 23010778
[TBL] [Abstract][Full Text] [Related]
17. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
18. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
19. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
Wang SE; Wu FY; Yu Y; Hayward GS
J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
